NPF
ABBV icon

Norris Perne & French’s AbbVie ABBV Stock Holding History

Norris Perne & French’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$531K Sell
2,109
-255
-11% -$54.9K 0.03% 96
2026
Q1 		$514K Sell
2,364
-1,128
-32% -$250K 0.03% 90
2025
Q4 		$798K Sell
3,492
-33
-0.9% -$7.52K 0.05% 90
2025
Q3 		$816K Buy
3,525
+515
+17% +$105K 0.06% 87
2025
Q2 		$559K Buy
3,010
+263
+10% +$48.9K 0.04% 96
2025
Q1 		$576K Hold
2,747
– – 0.04% 91
2024
Q4 		$488K Hold
2,747
– – 0.04% 94
2024
Q3 		$542K Buy
2,747
+60
+2% +$11.2K 0.04% 95
2024
Q2 		$461K Buy
2,687
+24
+0.9% +$3.98K 0.03% 98
2024
Q1 		$485K Sell
2,663
-236
-8% -$40.7K 0.03% 95
2023
Q4 		$449K Buy
2,899
+113
+4% +$16.5K 0.03% 90
2023
Q3 		$415K Buy
2,786
+400
+17% +$58.7K 0.04% 91
2023
Q2 		$321K Buy
2,386
+120
+5% +$17.6K 0.03% 105
2023
Q1 		$361K Buy
2,266
+181
+9% +$27.7K 0.03% 98
2022
Q4 		$337K Sell
2,085
-292
-12% -$44.8K 0.03% 105
2022
Q3 		$319K Sell
2,377
-75
-3% -$10.8K 0.03% 104
2022
Q2 		$376K Sell
2,452
-98
-4% -$15K 0.04% 96
2022
Q1 		$413K Sell
2,550
-1,200
-32% -$174K 0.03% 102
2021
Q4 		$508K Sell
3,750
-194
-5% -$22.9K 0.04% 93
2021
Q3 		$425K Sell
3,944
-50
-1% -$5.71K 0.04% 100
2021
Q2 		$450K Sell
3,994
-100
-2% -$11.3K 0.04% 97
2021
Q1 		$443K Sell
4,094
-24,500
-86% -$2.62M 0.04% 96
2020
Q4 		$3.06M Sell
28,594
-300
-1% -$28.8K 0.29% 62
2020
Q3 		$2.53M Sell
28,894
-502
-2% -$47.3K 0.28% 60
2020
Q2 		$2.89M Buy
29,396
+2,999
+11% +$264K 0.35% 54
2020
Q1 		$2.01M Sell
26,397
-175
-0.7% -$14.9K 0.3% 54
2019
Q4 		$2.35M Sell
26,572
-1,078
-4% -$89.5K 0.28% 58
2019
Q3 		$2.09M Sell
27,650
-100
-0.4% -$6.86K 0.26% 66
2019
Q2 		$2.02M Buy
27,750
+325
+1% +$25.5K 0.25% 65
2019
Q1 		$2.21M Sell
27,425
-750
-3% -$61.4K 0.29% 63
2018
Q4 		$2.6M Sell
28,175
-294
-1% -$25.9K 0.41% 60
2018
Q3 		$2.69M Sell
28,469
-1,227
-4% -$116K 0.35% 66
2018
Q2 		$2.75M Buy
29,696
+165
+0.6% +$16.1K 0.4% 63
2018
Q1 		$2.79M Sell
29,531
-125
-0.4% -$13.7K 0.41% 66
2017
Q4 		$2.87M Sell
29,656
-50
-0.2% -$4.71K 0.42% 65
2017
Q3 		$2.64M Sell
29,706
-6
-0% -$457 0.41% 67
2017
Q2 		$2.15M Sell
29,712
-625
-2% -$42K 0.36% 69
2017
Q1 		$1.98M Buy
30,337
+9,607
+46% +$604K 0.37% 70
2016
Q4 		$1.3M Sell
20,730
-15
-0.1% -$916 0.26% 75
2016
Q3 		$1.31M Sell
20,745
-390
-2% -$25.2K 0.27% 74
2016
Q2 		$1.31M Sell
21,135
-5,806
-22% -$354K 0.28% 70
2016
Q1 		$1.54M Buy
26,941
+150
+0.6% +$8.36K 0.32% 66
2015
Q4 		$1.59M Buy
26,791
+1,200
+5% +$69.1K 0.33% 68
2015
Q3 		$1.39M Buy
25,591
+1,750
+7% +$114K 0.33% 57
2015
Q2 		$1.6M Buy
23,841
+1,400
+6% +$91.4K 0.31% 65
2015
Q1 		$1.31M Buy
22,441
+325
+1% +$19.6K 0.24% 70
2014
Q4 		$1.45M Sell
22,116
-1,500
-6% -$94.6K 0.26% 74
2014
Q3 		$1.36M Sell
23,616
-2,800
-11% -$155K 0.26% 73
2014
Q2 		$1.49M Hold
26,416
– – 0.28% 74
2014
Q1 		$1.36M Buy
26,416
+391
+2% +$19.8K 0.27% 74
2013
Q4 		$1.37M Sell
26,025
-615
-2% -$30.2K 0.26% 75
2013
Q3 		$1.19M Buy
26,640
+1,550
+6% +$68.7K 0.25% 80
2013
Q2 		$1.04M Buy
+25,090
New +$1.1M 0.22% 83

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Norris Perne & French's ABBV Position: Q2 2026 in Review

Norris Perne & French reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $54.9K and leaving 2,109 shares worth $531K. The position accounts for 0.03% of the portfolio, ranked #96.

Norris Perne & French first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.06M in Q4 2020. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Norris Perne & French held 2,109 shares of AbbVie worth $531K as of Q2 2026.
  • Norris Perne & French sold 255 AbbVie shares in Q2 2026, an estimated $54.9K.
  • AbbVie made up 0.03% of Norris Perne & French's portfolio in Q2 2026, its #96 holding.
  • Norris Perne & French first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Norris Perne & French's AbbVie position peaked at $3.06M in Q4 2020.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Norris Perne & French's 13F filing for Q2 2026, filed 21 Jul 2026.